Search Results Search Sort by RelevanceMost Recent Podcast Nov 2024 Author Interview: “How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety?” Zachary Verne joins Ethics Talk to discuss his article, coauthored with Dr Jeffrey Zabinski: “How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety?” Medicine and Society Nov 2024 How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety? Zachary Verne and Jeffrey Zabinski, MD, MSW, MA This article examines widespread adoption of ketamine as a proxy for psychedelics. AMA J Ethics. 2024;26(11):E868-874. doi: 10.1001/amajethics.2024.868. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Podcast Nov 2024 Author Interview: “How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety?” Zachary Verne joins Ethics Talk to discuss his article, coauthored with Dr Jeffrey Zabinski: “How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety?”
Medicine and Society Nov 2024 How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety? Zachary Verne and Jeffrey Zabinski, MD, MSW, MA This article examines widespread adoption of ketamine as a proxy for psychedelics. AMA J Ethics. 2024;26(11):E868-874. doi: 10.1001/amajethics.2024.868.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
